Cargando…
Efficacy of polyglucosamine for weight loss—confirmed in a randomized double-blind, placebo-controlled clinical investigation
BACKGROUND: The purpose of this clinical study was to ascertain whether low molecular weight chitosan polyglucosamine is able to produce significantly better weight loss than placebo. METHOD: 115 participants were included in the study. We used a two-center randomized, double blind, placebo-controll...
Autores principales: | Pokhis, Karina, Bitterlich, Norman, Cornelli, Umberto, Cassano, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511026/ https://www.ncbi.nlm.nih.gov/pubmed/26217540 http://dx.doi.org/10.1186/s40608-015-0053-5 |
Ejemplares similares
-
Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity
por: Stoll, Manfred, et al.
Publicado: (2017) -
Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction
por: Cornelli, Umberto, et al.
Publicado: (2017) -
A Randomized Double-Blind Placebo-Controlled Clinical Study to Evaluate the Effect on the Weight of a Medical Device with Polyglucosamine L112 in a Group of Overweight and Obese Subjects
por: Rondanelli, Mariangela, et al.
Publicado: (2023) -
Effect of Polyglucosamine on Weight Loss and Metabolic Parameters in Overweight and Obesity: A Systematic Review and Meta-Analysis
por: Perna, Simone, et al.
Publicado: (2020) -
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed(®) Versus Placebo
por: Sinjari, Bruna, et al.
Publicado: (2020)